癌栄養学の世界市場 - 2023年：頭頚部癌・胃&消化器癌・肝臓癌・膵臓癌・食道癌・肺癌・乳癌・血液癌
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
|出版日||ページ情報||英文 97 Pages
|癌栄養学の世界市場 - 2023年：頭頚部癌・胃&消化器癌・肝臓癌・膵臓癌・食道癌・肺癌・乳癌・血液癌 Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023|
|出版日: 2018年04月30日||ページ情報: 英文 97 Pages||
癌栄養学市場は、2018年の14億6,000万米ドルから、2023年までに22億1,000万米ドルまで拡大すると見られ、予測期間中のCAGR (複合年間成長率) は、8.9%の成長が予測されています。市場の全体的な成長は主に、非経口から経腸栄養へのフォーカスの変化、癌発症率の増加、在宅部門における栄養摂取の需要の高まり、栄養不良の治療を受ける患者数の増加、および栄養学的介入に関する臨床研究の品質の向上に促進されています。消化態栄養剤の開発および同分野における製品革新も、同市場における大幅な成長機会を提供しています。しかし、経管栄養法に関連した合併症および医療費償還の制限は、癌栄養学市場の成長に大きな課題を提供しています。
The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions. The development of elemental formulas and product innovation in this field also provides significant growth opportunities in this market. However, the complications associated with tube feeding and limited reimbursement represent significant challenges to the market growth.
Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The head & neck cancers segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing incidence of head and neck cancers across the globe. Such patients see the major use of feeding formulas as severe conditions such as mucositis, xerostomia, dysgeusia, nausea, and vomiting limit their nutritional intake.
Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America commanded a major share of the oncology nutrition market. However, Asia Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia Pacific market is mainly attributed to the growing prevalence of chronic diseases & disorders, increasing number of preterm births, rising geriatric population, and increasing healthcare expenditure.
The players competing in this market are: Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).
The report analyzes the various types of nutritional formulas for cancer in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the oncology nutrition market for different cancer types and region. The report also includes in-depth company profiles of the key players in this market along with their product offerings, recent developments, and market strategies.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned four strategies for strengthening their market position.
The report provides insights on the following pointers: